Panel Detail

Sunday, September 9, 2012
9:40 AM - 10:30 AM

Patient Groups and the Drug Discovery Process


Bonnie Addario, Founder & Chair, President, Bonnie J. Addario Lung Cancer Foundation
Deborah Brooks, Co-founder and Executive Vice Chairman, The Michael J. Fox Foundation for Parkinson's Research
Peter Chiarelli, CEO, One Mind for Research; General (ret.), U.S. Army
Susan Solomon, CEO, The New York Stem Cell Foundation
Mary Woolley, President and CEO, Research!America


Margaret Anderson, Executive Director, FasterCures
"Patient groups with an entrepreneurial bent have become the drug industry's new power brokers," proclaimed Forbes magazine in 2008. More and more patient groups are deploying their limited capital more strategically, building collaborations, and sharing information, driven by their mission to get new treatments to their patients faster. These practices are the hallmarks of groups that are part of FasterCures' TRAIN (The Research Acceleration and Innovation Network) and will be the spotlight of this panel discussion. Why is it important for patient groups to be more deeply engaged in the R&D process, and why now? How are patient groups are accelerating the research process and "de-risking" the involvement and investment of other players such as government, academia and industry.

Panel Video

th patients

Click image above to play video